EDGE
Get a demo
Log In
All Updates

All Updates

icon
Filter
M&A
Darktrace potential USD 7 billion takeover deal fails
Next-gen Cybersecurity
Sep 9, 2022
This week:
Funding
Turbine secures investment from Accenture Ventures
AI Drug Discovery
May 17, 2024
FDA approval
Karius Receives FDA breakthrough designation for its DNA-based blood test
Precision Medicine
May 16, 2024
Funding
Metabolon raises USD 60 million in debt financing to strengthen R&D capabilities and enhance metabolomics platform
Precision Medicine
May 16, 2024
Partnerships
Accelerated Biosciences and Spanios partner to advance therapeutic design in solid tumor cancers
Precision Medicine
May 16, 2024
Partnerships
Telo Genomics and Emery Pharma put together their technologies to provide clinical R&D solutions
Precision Medicine
May 16, 2024
Partnerships
Oxford Biodynamics partners with KCL to enhance rheumatoid arthritis treatment using EpiSwitch technology
Precision Medicine
May 16, 2024
Funding
Monte Rosa Therapeutics prices USD 100 million underwritten public funding
Precision Medicine
May 16, 2024
Partnerships
Nearby Computing and Alea partner to streamline mission-critical communication app deployment
Edge Computing
May 16, 2024
M&A
Snowflake reportedly in talks to acquire Reka AI for more than USD 1 billion to expand language model capabilities
Foundation Models
May 16, 2024
Funding
Stability AI to reportedly raise funds to settle debt
Foundation Models
May 16, 2024
Next-gen Cybersecurity

Next-gen Cybersecurity

Sep 9, 2022

Darktrace potential USD 7 billion takeover deal fails

M&A

  • US-based private equity firm Thoma Bravo was in the preliminary stages of discussions last month to acquire the threat detection and response startup Darktrace for an all-cash transaction potentially valued at around GBP 6 billion (~USD 7 billion). The cash offer was open until the 12th of this month for Thoma Bravo to make an offer. Darktrace’s shares also rose by 17% following the acquisition announcement.

  • However, the deal was called off as both parties failed to reach an agreement on the terms of a firm offer. According to British acquisition rules, Thoma Bravo is prohibited from making an offer to acquire Darktrace for another six months unless another company makes a formal offer or reaches an agreement with the company’s board.

  • Darktrace currently has an employee headcount of more than 2,000 and has more than 30 offices. The company serves 7,437 customers (up 32.1% YoY) in 110 countries and it recorded USD 415 million in revenue during FY2022 (up 45.7% YoY).

  • Despite its full-year results showing rapid growth, investors sold off the company’s shares as the chances of the takeover slid away with Darktrace’s shares declining by nearly 35%.

Contact us

Gain access to all industry hubs, market maps, research tools, and more
Get a demo
arrow
menuarrow

By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.